Latest filings (excl ownership)
S-3ASR
Automatic shelf registration
5 Aug 24
S-8
Registration of securities for employees
5 Aug 24
10-Q
2024 Q2
Quarterly report
5 Aug 24
8-K
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
5 Aug 24
8-K
Departure of Directors or Certain Officers
3 Jun 24
8-K
Departure of Directors or Certain Officers
23 May 24
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
8 May 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
PRE 14A
Preliminary proxy
27 Mar 24
10-K
2023 FY
Annual report
21 Feb 24
8-K
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Entry into a Material Definitive Agreement
13 Feb 24
424B5
Prospectus supplement for primary offering
13 Feb 24
8-K
Other Events
13 Feb 24
8-K
Other Events
16 Jan 24
8-K
Departure of Directors or Certain Officers
19 Dec 23
8-K
Other Events
15 Dec 23
8-K
Entry into a Material Definitive Agreement
13 Dec 23
8-K
Other Events
8 Dec 23
8-K
Other Events
4 Dec 23
8-K
Other Events
16 Nov 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
6 Nov 23
8-K
CRISPR Therapeutics Announces Leadership Transition
7 Sep 23
S-8
Registration of securities for employees
7 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Results of Operations and Financial Condition
7 Aug 23
8-K
Departure of Directors or Certain Officers
9 Jun 23
8-K
Regulation FD Disclosure
9 Jun 23
DEFA14A
Additional proxy soliciting materials
18 May 23
10-Q
2023 Q1
Quarterly report
8 May 23
8-K
Results of Operations and Financial Condition
8 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
8-K
Regulation FD Disclosure
3 Apr 23
Latest ownership filings
4
Samarth Kulkarni
12 Aug 24
4
Julianne Bruno
24 Jun 24
4
Simeon George
31 May 24
4
Ali Behbahani
31 May 24
4
Sandesh Mahatme
31 May 24
4
Maria Fardis
31 May 24
4
John Greene
31 May 24
4
Christian Rommel
31 May 24
4
Katherine A High
31 May 24
4
Harold Edward Fleming
31 May 24
4
Douglas A Treco
31 May 24
3
Sandesh Mahatme
30 May 24
3
Christian Rommel
30 May 24
4
Naimish Patel
29 May 24
3
Naimish Patel
28 May 24
4
Julianne Bruno
24 May 24
3
Julianne Bruno
23 May 24
4
Samarth Kulkarni
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
SC 13G/A
Capital International Investors
10 Apr 24
4
JAMES R. KASINGER
22 Mar 24
4
Raju Prasad
22 Mar 24
4
Samarth Kulkarni
22 Mar 24
144
Notice of proposed sale of securities
22 Mar 24
4
Raju Prasad
18 Mar 24
4
Samarth Kulkarni
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
JAMES R. KASINGER
12 Mar 24
4
Samarth Kulkarni
12 Mar 24
4
Simeon George
27 Feb 24
4
JAMES R. KASINGER
21 Feb 24
4
Samarth Kulkarni
21 Feb 24
4
Samarth Kulkarni
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G/A
Nikko Asset Management Americas, Inc.
12 Feb 24
SC 13G/A
Capital International Investors
9 Feb 24
SC 13G/A
Sumitomo Mitsui Trust Holdings, Inc.
5 Feb 24
4
Samarth Kulkarni
31 Jan 24
144
Notice of proposed sale of securities
29 Jan 24
SC 13G/A
ARK Investment Management LLC
29 Jan 24